Histidine

Histidine

SCHEMBL3985699

Cl.Cl.N[C@@H](Cc1cnc[nH]1)C(=O)O

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Histidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HRH3 known ✓ Q9Y5N1 3/20 0.59
▸ GLA known ✓ P06280 1/20 0.56
▸ CYP3A4 P08684 1/20 0.97
▸ SLC7A5 Q01650 1/20 0.97
▸ ALDH1A1 P00352 3/20 0.59
▸ HRH4 Q9H3N8 3/20 0.59
▸ LMNA P02545 1/20 0.59
▸ APEX1 P27695 1/20 0.59
▸ BLM P54132 1/20 0.59
▸ CPB2 Q96IY4 1/20 0.57
▸ MEN1 O00255 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ PMP22 Q01453 1/20 0.56
▸ CYP1A2 P05177 1/20 0.56
▸ NFKB1 P19838 1/20 0.56
▸ THPO P40225 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Histidine SCHEMBL16893960 1.00 CYP3A4 (0.97) CYP3A4SLC7A5ALDH1A1HRH4HRH3
D-Histidine SCHEMBL8002459 1.00 CYP3A4 (0.97) CYP3A4SLC7A5ALDH1A1HRH4HRH3
Histidine SCHEMBL5134199 1.00 CYP3A4 (0.97) CYP3A4SLC7A5ALDH1A1HRH4HRH3
Histidine SCHEMBL209484 1.00 CYP3A4 (0.97) CYP3A4SLC7A5ALDH1A1HRH4HRH3
Histidine SCHEMBL2228758 1.00 CYP3A4 (0.97) CYP3A4SLC7A5ALDH1A1HRH4HRH3
Histidine SCHEMBL357639 0.98 CYP3A4 (0.93) CYP3A4SLC7A5ALDH1A1HRH4HRH3
Histidine SCHEMBL31618930 0.98 CYP3A4 (0.93) CYP3A4SLC7A5ALDH1A1HRH4HRH3
Histidine SCHEMBL1705391 0.98 CYP3A4 (0.93) CYP3A4SLC7A5ALDH1A1HRH4HRH3
Histidine SCHEMBL28330064 0.98 CYP3A4 (0.93) CYP3A4SLC7A5ALDH1A1HRH4HRH3
D-Histidine SCHEMBL3639231 0.98 CYP3A4 (0.93) CYP3A4SLC7A5ALDH1A1HRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3997056-A1 NEW METHOD FOR PREPARING AN INSECT REPELLENT AGENT Centre national de la recherche scientifique (FR) 2022-05-18 — — EP claimed
WO-2021005214-A1 NEW METHOD FOR PREPARING AN INSECT REPELLENT AGENT CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2021-01-14 — — WO claimed
CN-106178988-B A kind of polyvinylidene fluoride blending film of photosynthesis-carbon dioxide response and preparation method thereof 台州学院 2019-09-24 — — CN claimed
EP-2739282-B1 NEW USE OF L-HISTIDINE AND DERIVATIVES THEREOF BRACCO IMAGING SPA (IT) 2017-01-11 — — EP claimed
CN-103717220-B The purposes of L-Histidine and derivative thereof BRACCO IMAGING S.P.A. (IT) 2016-05-11 — — CN claimed
US-9012483-B2 Use of L-Histidine and derivatives thereof BRACCO IMAGING S.P.A. (IT) 2015-04-21 — — US claimed
EP-2739282-A1 NEW USE OF L-HISTIDINE AND DERIVATIVES THEREOF Bracco Imaging S.p.A (IT) 2014-06-11 — — EP claimed
US-20140155449-A1 NEW USE OF L-HISTIDINE AND DERIVATIVES THEREOF BRACCO IMAGING S.P.A. (IT) 2014-06-05 — — US claimed
CN-103717220-A New use of L-histidine and derivatives thereof BRACCO IMAGING SPA 2014-04-09 — — CN claimed
WO-2013017475-A1 NEW USE OF L-HISTIDINE AND DERIVATIVES THEREOF BRACCO IMAGING SPA (IT) 2013-02-07 — — WO claimed
EP-2554167-A1 New use of l-histidine and derivatives thereof Bracco Imaging S.p.A (IT) 2013-02-06 — — EP claimed
CN-100394555-C Method of second step polishing in copper CMP with a polishing fluid containing no oxidizing agent CMP ROHM AND HAAS ELECTRONIC M (US) 2008-06-11 — — CN claimed
EP-1526163-B1 Method of second step polishing in copper CMP with a polishing fluid containing no oxidizing agent ROHM & HAAS ELECT MAT (US) 2007-08-08 — — EP claimed
US-20050090106-A1 Method of second step polishing in copper CMP with a polishing fluid containing no oxidizing agent ROHM AND HAAS ELECTRONIC MATERIALS CMP HOLDINGS, INC. 2005-04-28 — — US claimed
EP-1526163-A1 Method of second step polishing in copper CMP with a polishing fluid containing no oxidizing agent Rohm and Haas Electronic Materials CMP Holdings, Inc. (US) 2005-04-27 — — EP claimed
CN-1610072-A Method of second step polishing in copper CMP with a polishing fluid containing no oxidizing agent CMP ROHM AND HAAS ELECTRONIC M (US) 2005-04-27 — — CN claimed
US-20030065239-A1 Non-hazardous basic neutralization of aldehydes ETHICON, INC. 2003-04-03 — — US claimed
EP-0513361-B1 METHOD OF ASSAYING ENDOTOXIN SEIKAGAKU KOGYO CO LTD (JP) 1996-12-04 — — EP claimed
US-5378610-A Surfactants, incubation and analyzing for endotoxins SEIKAGAKU KOGYO KABUSHIKI KAISHA (SEIKAGAKU CORPORATION) (JP) 1995-01-03 — — US claimed
EP-0513361-A1 METHOD OF ASSAYING ENDOTOXIN SEIKAGAKU KOGYO KABUSHIKI KAISHA (SEIKAGAKU CORPORATION) (JP) 1992-11-19 — — EP claimed
Send feedback